From a strategic perspective, RxLogix proactively seeks innovative solutions as preemptive strikes against second-rate thinking. RxLogix is a .. Read more one-stop-shop for all PV needs applying most recent technology advances like machine learning, artificial intelligence and best practice methodological approaches. Recently, after a thorough evaluation of commercially available signaling and analytical software vendors, the FDA selected RxLogix’s PV Surveillance Suite Platform, replacing its legacy FAERS signaling system. FDA has decided to implement RxLogix PV Surveillance Suite (Modules – PV Reports, PV Signal, PV Analytics and PV Datahub) for advanced data analytics, signal detection, evaluation, signal management and benefit-risk assessment. We are passionate about patient’s safety and innovative solutions in both technology and business areas. It is our commitment to innovate and collaborate with all parties involved in the Pharmacovigilance landscape. We are passionately obsessed with our mission of patient safety, solving a complex problem and explaining possible solutions in everyday language.
- Share your Experience
RxLogix Corporation, Inc.USA 5 Total Events / 1 Upcoming Event
More Events From The Organizer
- RxLogix: PV Publisher: Automat..09 Dec 2020Online